Metoprolol is used to treat angina (chest pain) and hypertension (high blood pressure). The most frequent adverse effects are dizziness, tiredness, insomnia, and gastric upset.The most common adverse cardiovascular effects of metoprolol are shortness of breath and bradycardia, occurring in about 3% of patients with hypertension or angina receiving metoprolol tartrate in clinical trials. The usual oral maintenance dosage for ongoing treatment of SVT is 200 mg twice daily (as metoprolol tartrate tablets) or 400 mg once daily (as metoprolol succinate extended-release tablets).Prior to initiation of therapy with a β-blocker in patients with heart failure, the dosage of any concomitant heart failure therapy should be stabilized. Because FSA funds are available to you on the first day of your plan year, you must be able to receive full reimbursement for your contribution. can provide you with an itemized receipt after you make your order to submit to your FSA Administrator for FSA reimbursement. The manufacturer recommends that metoprolol tartrate be administered with or immediately following meals. Patients who appear not to tolerate the usual total IV dose should initially receive an oral metoprolol tartrate dosage of 25 or 50 mg (depending on the degree of intolerance) every 6 hours beginning 15 minutes after the last IV dose or as soon as their clinical condition allows. So, if you opted in for $1,200 a year for your FSA, you could use that amount on the first day (if you wanted to). The manufacturers state that oral dosages in terms of metoprolol tartrate should not exceed 450 mg daily as conventional tablets or 400 mg daily as extended-release tablets; dosages of the respective formulations exceeding these have not been studied.Some experts recommend a lower usual dosage range of 50-100 mg daily, given in 1 or 2 divided doses daily as conventional tablets or once daily as extended-release tablets.


Antiarrhythmic drug therapy usually is reserved for patients who do not respond to initial attempts at correcting or managing potential precipitating factors (e.g., exacerbation of COPD or congestive heart failure, electrolyte and/or ventilatory disturbances, infection, theophylline toxicity) or in whom a precipitating factor cannot be identified. = Metoprolol (156,17 mg pro 1 Tablette) Allergic reactions reported in patients receiving other β-blockers include erythematous rash, fever combined with aching and sore throat, laryngospasm, and respiratory distress. If there is an inadequate response to atropine, IV isoproterenol may be administered with caution. Was sollten Sie beachten? However, such diminished response to a β-blocker is largely eliminated when the drug is administered concomitantly with a thiazide diuretic. Exercise tolerance may decrease in patients with left ventricular dysfunction. If goal blood pressure is not achieved with initial monotherapy with one of the recommended antihypertensive drug classes, a second drug from one of the recommended drug classes may be added; if goal blood pressure is still not achieved with optimal dosages of 2 antihypertensive agents, a third drug from one of the recommended drug classes may be added. Orders placed on weekends or holidays will not be shipped until the next business day. Patients receiving metoprolol also had substantial reductions in ventricular fibrillation and chest pain.Studies conducted after the widespread use of reperfusion therapy generally have demonstrated more attenuated benefits with early β-blocker therapy in patients with acute MI; while β-blockers may still confer benefits (e.g., reduction in the risk of reinfarction and ventricular arrhythmias), there is less certainty regarding the drugs' effects on mortality in patients receiving contemporary revascularization and pharmacologic therapies (antiplatelet agents, ACE inhibitors, and lipid-lowering therapies). Rarely, impotence, nervousness, and general weakness have occurred.

The drug is contraindicated in patients with acute MI who have a heart rate less than 45-60 beats/minute, heart block greater than first degree, systolic blood pressure less than 100 mm Hg, or moderate to severe cardiac failure.